Lecanemab, the Drug That Slows the Progression of Alzheimer’s, Gets Accelerated ApprovalLecanemab (also known as Leqembi) is a monoclonal antibody drug that is being developed by Biogen as a treatment for… By Tommy Hunter, in Health News on January 8, 2023 .
